Regulation - Rest of the World, Biotechnology

Filter

Popular Filters

Protalix gains Israeli approval for Gaucher drug Elelyso

01-10-2012

ael-based Protalix BioTherapeutics (NYSE-AMEX: OLX) has received marketing authorization from the Israeli…

BiotechnologyElelysoPharmaceuticalProtalix BioTherapeuticsRare diseasesRegulationRest of the World

Parexel

Parexel

Back to top